Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.
Authors
Blanc, F-XSok, T
Laureillard, D
Borand, L
Rekacewicz, C
Nerrienet, E
Madec, Y
Marcy, O
Chan, S
Prak, N
Kim, C
Lak, K K
Hak, C
Dim, B
Sin, C I
Sun, S
Guillard, B
Sar, B
Vong, S
Fernandez, M
Fox, L
Delfraissy, J-F
Goldfeld, A E
Affiliation
Pneumology Unit, Internal Medicine Department, Bicêtre Hospital, Assistance Publique–Hôpitaux de Paris, Le Kremlin-Bicêtre, France. xavier.blanc@bct.aphp.frIssue Date
2011-10-20
Metadata
Show full item recordJournal
New England Journal of MedicineAbstract
Tuberculosis remains an important cause of death among patients infected with the human immunodeficiency virus (HIV). Robust data are lacking with regard to the timing for the initiation of antiretroviral therapy (ART) in relation to the start of antituberculosis therapy.PubMed ID
22010913Language
enISSN
1533-4406ae974a485f413a2113503eed53cd6c53
10.1056/NEJMoa1013911